In a set of newly released presentations, officials from the US Food and Drug Administration (FDA) explain changes to the agency's biomarker qualification program and detail early opportunities for ...

A long-standing goal of cancer research has been to identify the molecular mechanisms by which cancers develop, and then to detect those molecular markers of cancers early and to target those ...

The world is currently undergoing a significant transformation in biomarker science. Biomarker signatures are no longer academic luxury or exploratory afterthoughts; they have matured into strategic ...